New Releases from NCBI BookshelfEpcoritamab for treating relapsed or refractory follicular lymphoma after 2 or more lines of systemic treatment.Epcoritamab for treating relapsed or refractory follicular lymphoma after 2 or more lines of systemic treatment.
Post Content
